TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Galectin Therapeutics Inc (NASDAQ: GALT) Investor Securities Class Action Lawsuit 07/30/2014

  • If you purchased shares Galectin Therapeutics Inc (NASDAQ: GALT) you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

December 30, 2015 - The court dismissed the case with prejudice. June 26, 2015 - Defendants filed a motion to dismiss. May 8, 2015 - The lead plaintiff filed a consolidated complaint on behalf of investors who purchased Galectin Therapeutics Inc (NASDAQ: GALT) common shares between October 25, 2013 and July 28, 2014. The lead plaintiff alleges that the defendants violated the Securi...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: